AsiaOne has launched EarthOne, a new section dedicated to environmental issues — because we love the planet and we believe science. Find articles like this there.
SHANGHAI - China should raise air quality standards as persistent smog continues to have a severe public health impact despite recent improvements, a state-funded task force said.
After a campaign launched in 2013 to tackle smog, air pollution in China has improved markedly. Average concentrations of small, hazardous airborne particles known as PM2.5 fell by about half from 2015 levels to 30 micrograms per cubic metre last year, official data shows.
But while China met its interim target of 35 micrograms, it remains far above the 5-microgram limit recommended by the World Health Organization (WHO). Some parts of the industrial north still have smog levels close to 200 micrograms, especially in the winter.
Beijing needs to revise national air pollution standards and improve legal protections for human health, the task force commissioned by China's national pollution research programme said on Friday (April 25).
"The acute health risk of ambient PM2.5 pollution usually means that short-term exposure to PM2.5... may cause acute damage to the body, trigger the onset of symptoms or diseases (mainly cardiovascular or respiratory disease) and lead to premature death and a series of adverse health effects," it said in a report.
Recent studies show that each 10-microgram increase was associated with a 0.34 per cent increase in the risk of hospitalisation for respiratory diseases, the report said.
[[nid:571291]]
It urged the government to further promote clean energy, upgrade industries and control transportation pollution, adding that China's goal of carbon neutrality was a crucial part of its efforts to meet WHO recommendations.
It called for improvements in data and a more systematic study of the health effects of air pollution, including the impact of "key toxic components" on human biomarkers.
Air pollution in China caused about 1.4 million premature deaths in 2019, according to the Global Burden of Disease Study, a programme run by the University of Washington.